We were honored to welcome team members from Esperion, a global biopharmaceutical company, to this year’s NYC Awards Night. Representing the company were Betty Swartz, Chief Business Officer; Amy Wilson, Chief Compliance Officer; Donna Florio, Head of Field Reimbursement and Access Strategy; Maggie Glassman, Executive Director, Market Access; Evelyn Sarnes, Executive Director, Health Economics and Outcomes Research; and Lisa Schafer, VP, Head of Marketing.
Esperion Therapeutics is focused on cardiovascular disease management, with two treatments approved in both the U.S. and Europe based on a unique mechanism of action. The company continues to evolve through commercial execution, international partnerships and collaborations, and advancement of its pre-clinical pipeline, with a scientific team leading the investigation of ACLY biology having brought the first ACLY inhibitor to market.
Thanks to the Esperion team for joining us in New York for this year’s event.
The next Healthcare Technology Report and GrowthCap Forum event will take place this summer in Jackson Hole, WY. Learn more here.
Picture: Maggie Glassman, Donna Florio, Betty Swartz, Amy Wilson, Lisa Schafer, and Evelyn Sarnes at NYC Awards Night.